
42.55 Delayed Data As of Jul 01 | ![]() Today’s Change | 34.90 Today|||52-Week Range 108.47 | -48.20% Year-to-Date |
Arvinas, Inc. (ARVN) Stock Jumps 8%: Will It Continue to Soar? Jun 27 / Zacks.com - Paid Partner Content |
Previous close | 42.09 |
Today’s open | 41.57 |
Day’s range | 40.97 - 42.61 |
Volume | 6,305 |
Average volume (3 months) | 475,193 |
Market cap | $2.4B |
Earnings growth (last year) | -26.56% |
Earnings growth (this year) | -16.00% |
Earnings growth (next 5 years) | -13.13% |
Revenue growth (last year) | +114.20% |
P/E ratio | NM |
Price/Sales | 87.94 |
Price/Book | 3.11 |
---- | ||
FATEFate Therapeutics In... | +0.39 | +1.57% |
TWSTTwist Bioscience Cor... | +2.14 | +6.12% |
BCRXBioCryst Pharmaceuti... | +0.26 | +2.46% |
Next reporting date | August 9, 2022 |
EPS forecast (this quarter) | -$1.09 |
Annual revenue (last year) | $46.7M |
Annual profit (last year) | -$191.0M |
Net profit margin | -408.99% |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters New Haven, Connecticut |